23 April, 2017

The USPSTF has upgraded its recommendation about PSA screening for prostate cancer from a D (the harms outweigh the benefits) to a C (it’s an individual decision). Yet, there is no proof that PSA screening extends your life, improves the years you have, or reduces your risk of dying.


No comments: